Vertex Pharmaceuticals Incorporated · VRTX
As of the latest run, Vertex Pharmaceuticals Incorporated (VRTX) scores 64/100 overall — a broadly solid profile. Its strongest dimension: momentum (86/100); the one that most warrants attention: valuation (33/100).
Three pillars judge the company (profitability, growth, financial health), three judge the stock (valuation, momentum, risk). The score is recomputed every day from Yahoo Finance market data — the one shown above reflects today's state.
Momentum comes in at 86/100 — a well-oriented price trend. The risk pillar comes in at 76/100 — volatility kept in check by market standards. Growth comes in at 75/100 — sustained revenue growth.
The breakdown of each pillar — and a plain-English explanation of what it measures — is available in the full analysis, free and updated every day.
Valuation falls to 33/100 — a stretched price relative to the stock's own valuation history.
No score replaces your own judgment: Stock Analyzer is a tool for analysis and understanding, not investment advice.